Bonito elastin peptide improves biophysical properties in aging skin

A recent study found that Bonito elastin peptide (VGPG Elastin®) when taken orally has been shown to diminish fine wrinkles, lower melanin levels, and improve skin hydration. This study’s results were published in the journal, Skin research and technology.

In this double-blinded, randomized, placebo-controlled trial, a total of 100 participants were randomly divided into two groups, with one group receiving a test product that contained 100 mg of Bonito elastin peptide (VGPG Elastin®), while the other group received a placebo. The parameters of hydration, skin wrinkles, and brightening (melanin index) were measured at the start of the study and subsequently at 4, 8, and 12 weeks after the intervention.

After 12 weeks of intervention, the test group demonstrated considerable enhancements in average skin roughness, maximum peak height of the wrinkle, maximum peak-to-valley values,  average maximum height of the wrinkle, maximum valley depth of the wrinkle, and eye wrinkle volume when compared to the placebo group. Additionally, skin hydration levels improved, and the melanin index was significantly lower in the test group than in the placebo group. Notably, no adverse events related to the test product were reported by any participant.

Thus, it can be concluded that oral consumption of Bonito elastin peptide (VGPG Elastin®) effectively reduces the appearance of fine wrinkles, decrease melanin index, and improve skin hydration. These findings suggest that it may be a potential treatment option for combating wrinkles, dryness, and pigmentation issues.